Patient?treatment matching with anti?craving medications in alcohol?dependent patients: A review on phenotypic, endophenotypic and genetic indicators
- 1 April 2005
- journal article
- review article
- Published by Informa UK Limited in Journal of Substance Use
- Vol. 10 (2-3), 75-96
- https://doi.org/10.1080/14659890500038764
Abstract
Objectives: Craving plays an important role in the development and maintenance of alcohol dependence and in relapse after periods of abstinence. Anti‐craving compounds, such as acamprosate, naltrexone or serotonergic compounds, are found to be only moderately effective. These moderate effects might be due to inadequate matching of specific patients to specific treatments. In 1999, Verheul et al. proposed a three‐pathway model of craving in alcoholics, which hypothesised that reward drinkers would better respond to naltrexone, relief drinkers to acamprosate and obsessive drinkers to serotonergic compounds. However, these matching hypotheses are not yet validated. This article reviews the literature on predictors and matching variables of the effectiveness of pharmacological interventions in alcohol dependent patients directed at the reduction of craving and the prevention of relapse. Methods: Studies were selected through a literature search in September 2004, focusing on matching or predicting variables for anti‐craving compounds in the treatment of alcoholics. Matching or predicting variables were categorised as either phenotypic (e.g., level of baseline anxiety), endophenotypic (e.g., physiological cue reactivity) or genetic (e.g., µ opioid receptor polymorphisms). Results: Studies using clinical or phenotypic effect modifiers have produced inconsistent and rather disappointing results. In contrast, the predictive value of genetic effect modifiers are quite promising (e.g., µ opioid receptor polymorphisms). No studies that looked at endophenotypic predicting or matching variables were identified. Conclusion: It is concluded that phenotypic matching variables might be too distal, i.e., far removed from the pathogenic process, and that matching research should shift its attention toward more proximal variables (e.g., genetic and endophenotypic variables).Keywords
This publication has 58 references indexed in Scilit:
- Gender Differences in Response to Sertraline Pharmacotherapy in Type A Alcohol DependenceThe American Journal on Addictions, 2004
- The Efficacy of Acamprosate in the Maintenance of Abstinence in Alcohol‐Dependent Individuals: Results of a Meta‐AnalysisAlcohol: Clinical and Experimental Research, 2004
- Dual blomarkers corroborate efficacy of combining ondansetron and naltrexone for the treatment of biological alcoholismEuropean Neuropsychopharmacology, 2002
- Confirmation That Offspring From Families With Alcohol‐Dependent Individuals Have Greater Hypothalamic‐Pituitary‐Adrenal Axis Activation Induced by Naloxone Compared With Offspring Without a Family History of Alcohol DependenceAlcohol: Clinical and Experimental Research, 2001
- Alcohol-associated stimuli activate the ventral striatum in abstinent alcoholicsJournal of Neural Transmission, 2001
- Identifying a multivariate endophenotype for substance use disorders using psychophysiological measuresInternational Journal of Psychophysiology, 2000
- Naltrexone Alters Subjective and Psychomotor Responses to Alcohol in Heavy Drinking SubjectsNeuropsychopharmacology, 2000
- Effects of Naltrexone on Alcohol Self‐Administration in Heavy DrinkersAlcohol: Clinical and Experimental Research, 1999
- Efficacy of Buspirone in Alcohol Dependence: A ReviewAlcohol: Clinical and Experimental Research, 1996
- The neural basis of drug craving: An incentive-sensitization theory of addictionBrain Research Reviews, 1993